Study of the Efficacy and Safety of Nicotinamide in Patients With Liver Fibrosis (NICOFIB)

Clinical trial NCT06599918 · RECRUITING

Trial details

NCT number: NCT06599918
Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Fatty Liver Obesity Hepatic Fibrosis NAFLD Nicotinamide Overweight and Obese Adults

Start date: 2024-04-23
Primary completion: 2027-12-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.